Apple
AAPL
Taylor Morrison Home
TMHC
D.R. Horton
DHI
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
US Stock MarketDetailed Quotes
RNXT RenovoRx
- 1.020
- 0.0000.00%
Close Mar 27 16:00 ET
- 1.098
- +0.078+7.63%
Pre 08:02 ET
36.28MMarket Cap-1.76P/E (TTM)
1.060High1.010Low53.88KVolume1.040Open1.020Pre Close55.87KTurnover0.15%Turnover RatioLossP/E (Static)35.57MShares1.69052wk High5.13P/B35.81MFloat Cap0.77452wk Low--Dividend TTM35.11MShs Float16.740Historical High--Div YieldTTM4.90%Amplitude0.531Historical Low1.036Avg Price1Lot Size
About RenovoRx Company
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Mountain View, CA.
Company Profile
SymbolRNXT
Company NameRenovoRx
Listing DateAug 26, 2021
Issue Price9.00
Founded2012
CEOMr. Shaun R. Bagai
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address2570 West El Camino Real,Suite 320
CityMountain View
ProvinceCalifornia
CountryUnited States of America
Zip Code94040
Phone1-650-284-4433
Websitehttp://www.renovorx.com
Company Executives
- Name
- Position
- Salary
- Shaun R. Bagai
- Chief Executive Officer and Director
- 939.12K
- Leesa Gentry
- Chief Clinical Officer
- --
- Dr. Ramtin Agah, M.D.
- Chief Medical Officer and Chairman of the Board
- 507.76K
- Ronald B. Kocak
- Vice President, Controller and Principal Accounting Officer
- --
- Kirsten Angela Macfarlane
- Independent Director
- 82.00K
- Dr. Una S. Ryan,PhD
- Independent Director
- 82.00K
- Dr. Robert J. Spiegel, F.A.C.P.,M.D.
- Independent Director
- 173.72K
- Dr. Laurence J. Marton, M.D.
- Independent Director
- 77.00K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.